• Products
    Overview
    LiverMultiScan MRCP+ Digital Pathology Perspectum Portal ATLAS Hepatica
  • Patients
    Overview
    Patient Stories Patient Resources Liver Disease
  • Professionals
    Overview
    Gastroenterology and Hepatology Radiology Clinical Evidence Imaging Provider
  • Pharma Solutions
    Overview
    NASH & NAFLD Oncology IBD Cholestatic Liver Disease Frequently Asked Questions
  • Technology Locations
  • Research
    Overview
    Research Projects Publications
  • Our Company
    Overview
    Senior Management Board of Directors Careers Events Webinars News Contact
  • Customer Login
  • Home
  • Research
  • Research Projects
  • London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare

London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare

 

Summary

Development and clinical evaluation of AI tools for detection and therapy response in liver cancer using diagnostic and prognostic biomarkers.

Disease Area

Cancer

Product

Hepatica

Status

In Progress, Not Recruiting

Country

UK

Latest News:

  • LiverMultiScan® detected earlier stages of treatable disease in patients with autoimmune hepatitis to allow tailored treatment
  • LiverMultiScan® has achieved nationwide payer coverage for diagnosis and management of NAFLD and other established chronic liver diseases
  • First patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study using Perspectum’s imaging technology to help predict disease progression and guide patient management
What We Do
  • Patients
  • Products
  • Professionals
  • Research
Company
  • Our Company
  • Senior Management
  • Life at Perspectum
  • Careers
Insights
  • News
  • Events
  • Media Centre
  • Case Studies

Join our newsletter
Subscribe Now

©2022 Perspectum.

Excellence | Accountability | Integrity | Openness | Passion

  • Privacy & Cookies and Data Storage Policy
  • Terms and Conditions
  • Customer Trademark Licence (“Licence”)